Mandate

Vinge advises Investor Growth Capital on the investment in Memira Holding AB

October 02, 2007

Vinge advises Investor Growth Capital in connection with the investment in Memira Holding AB, a Scandinavian laser eye surgery chain. Memira’s surgeries treat short and long sightedness as well as astigmatism, which is a common refractive error. The investment in the company will make Investor Growth Capital the owner of 40 per cent of the shares.

Investor Growth Capital is represented by partner Johan Winnerblad assisted by associates Johan Larsson, Tom Zachrisson and Theresa Kovac.

Related

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026